"If TLX can have a 2 billion dollar market cap on only a single commercial imaging agent that has a smaller addressable market than the agent IBX is developing then I can see them following in their footsteps should they get to commercialisation."
WOW, thank you for bringing this up. Just visited TLX thread and found they have commercialised Illuccix already in USA, Canada and Australia. More countries in Europe are on its way. I am afraid IBX will be outpaced by them although they are using radioisotope, sort of radiation vs IBX non-radioactive ones. BUT does it really matter? If IBX cannot get the phase 1 dusted in time, will the patients/medical doctor wait for IBX?
IBX Price at posting:
2.3¢ Sentiment: Hold Disclosure: Held
